Krystal Biotech (KRYS) Times Interest Earned (2016 - 2026)
Krystal Biotech (KRYS) reported Times Interest Earned of $0.19 for Q1 2026, up 2.91% on a YoY basis from $0.18 in Q1 2025, and up 26.6% sequentially from $0.15 in Q4 2025.
Krystal Biotech (KRYS) Times Interest Earned (2016 - 2026) Analysis & Trends
Krystal Biotech (KRYS) has 11 years of Times Interest Earned data on file, last reported at $0.19 in Q1 2026.
- For the quarter ending Q1 2026, Times Interest Earned rose 2.91% year-over-year to $0.19; the trailing twelve-month figure through Mar 2026 stood at $0.62 (up 14.24% YoY), and the FY2025 full-year result was $0.54, up 28.47% from the prior year.
- Times Interest Earned improved to $0.19 in Q1 2026, from $0.15 in the prior quarter.
- In the past five years, Times Interest Earned ranged from a high of $0.34 in Q2 2025 to a low of -$1.65 in Q1 2022.
- A 5-year average of -$0.2 and a median of $0.03 in 2023 frame the typical range for Times Interest Earned.
- Across the five-year window, Times Interest Earned sank 250.84% in 2022 and surged 1125.0% in 2024, its largest moves.
- Tracing KRYS's Times Interest Earned over 5 years: stood at -$0.85 in 2022, then jumped by 102.56% to $0.02 in 2023, then surged by 1125.0% to $0.26 in 2024, then slumped by 43.97% to $0.15 in 2025, then grew by 26.6% to $0.19 in 2026.
- Business Quant data shows KRYS's Times Interest Earned at $0.19 in Q1 2026, $0.15 in Q4 2025, and $0.23 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -157.58 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 7.60 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -0.38 |
| 10 | Krystal Biotech | 9.84 Bn | 9.02 Bn | 110.08 Mn | 0.19 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.19 |
| Dec 31, 2025 | 0.15 |
| Sep 30, 2025 | 0.23 |
| Jun 30, 2025 | 0.34 |
| Mar 31, 2025 | 0.18 |
| Dec 31, 2024 | 0.26 |
| Sep 30, 2024 | 0.11 |
| Jun 30, 2024 | 0.04 |
| Mar 31, 2024 | -0.03 |
| Dec 31, 2023 | 0.02 |
| Sep 30, 2023 | -0.19 |
| Jun 30, 2023 | -0.22 |
| Mar 31, 2023 | -0.74 |
| Sep 30, 2022 | -0.85 |
| Jun 30, 2022 | -1.01 |
| Mar 31, 2022 | -1.65 |
| Sep 30, 2021 | -1.66 |
| Jun 30, 2021 | -0.72 |
| Mar 31, 2021 | -0.47 |
| Sep 30, 2020 | -1.60 |